| __timestamp | Regeneron Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 1488000000 |
| Thursday, January 1, 2015 | 1620577000 | 1525000000 |
| Friday, January 1, 2016 | 2052295000 | 2111000000 |
| Sunday, January 1, 2017 | 2075142000 | 1848000000 |
| Monday, January 1, 2018 | 2186100000 | 1213000000 |
| Tuesday, January 1, 2019 | 3036600000 | 1010000000 |
| Wednesday, January 1, 2020 | 2735000000 | 997000000 |
| Friday, January 1, 2021 | 2908100000 | 967000000 |
| Saturday, January 1, 2022 | 3592500000 | 838000000 |
| Sunday, January 1, 2023 | 4439000000 | 953000000 |
| Monday, January 1, 2024 | 5132000000 | 998000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited have been at the forefront of this race. From 2014 to 2023, Regeneron has consistently increased its investment in research and development (R&D), culminating in a staggering 250% increase by 2023. In contrast, Teva's R&D spending has seen a decline, dropping by approximately 36% over the same period.
Regeneron's commitment to innovation is evident, with its R&D expenses peaking at $4.4 billion in 2023, compared to Teva's $953 million. This strategic focus on R&D has positioned Regeneron as a leader in pharmaceutical innovation, while Teva's reduced investment may impact its competitive edge. As the industry evolves, these investment trends highlight the critical role of R&D in driving future growth and success.
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: AstraZeneca PLC vs Teva Pharmaceutical Industries Limited
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and ImmunityBio, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Incyte Corporation: Strategic Focus on R&D Spending
R&D Insights: How Teva Pharmaceutical Industries Limited and Geron Corporation Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Evotec SE